Allen Mary | Drug Metabolism Department Central Research Division Pfizer Inc.
スポンサーリンク
概要
関連著者
-
Allen Mary
Drug Metabolism Department Central Research Division Pfizer Inc.
-
Stafford Caroline
Drug Metabolism Department Central Research Division Pfizer Inc.
-
Day Wesley
Drug Metabolism Department Central Research Division Pfizer Inc.
-
NOCERINI Mark
Drug Metabolism Department, Central Research Division, Pfizer Inc.
-
Nocerini Mark
Drug Metabolism Department Central Research Division Pfizer Inc.
著作論文
- Determination of 1-[5-(2-cyclopropyl-5,7-dimethyl-imidazo[4,5-b]pyridin-3-ylmethyl)thiophen-2-yl]cyclopent-3-enecarboxylic acid (CP-191,166), an angiotensin II antagonist, in dog and rat plasma by high-performance liquid chromatography
- Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2-{2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino}propionylamino)butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbo